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Mouse mammary tumor viruses (MMTVs) encode superantigens that associate with major histocompatibility complex
class II products on antigen-presenting cells and stimulate T cells in a Vb-specific manner. This T cell activation is critical
for completion of the viral life cycle and vertical transmission to the next generation. To investigate the functional significance
of extensive viral superantigen (Sag) glycosylation, we disrupted the six potential sites for N-linked carbohydrate addition
in the Sag encoded by proviral integrant Mtv-1. Shifts in the apparent molecular mass of these mutant glycoproteins
suggested that wild-type Mtv-1 Sag is glycosylated on four of its six sites. Intracellular and cell surface staining of the
panel of mutants indicated that any decrease in glycosylation resulted in reduced levels of intracellular protein and undetect-
able surface expression, suggesting that decreased glycosylation leads to rapid Sag degradation and abates trafficking to
the plasma membrane. Nevertheless, several mutants with intermediate levels of glycosylation expressed enough Sag on
the B cell surface to potently stimulate reactive T cell hybrids. We show there is no specific site bearing N-linked glycosylation
that is essential for activity, but at least one carbohydrate addition is necessary for effective B cell presentation of MMTV
superantigens to T cells. q 1997 Academic Press
INTRODUCTION mines TCR Vb specificity (Yazdanbaksh et al., 1993).
Thus, different Sags are able to stimulate distinct subsets
The mouse mammary tumor virus 3* long terminal re- of the T cell repertoire.
peat is unusual in that it contains an open reading frame. The Sag glycoprotein plays a crucial role in the life
The encoded glycoprotein has been dubbed a viral ‘‘su- cycle of MMTV. Milk-borne virus infects B cells in the
perantigen’’ (Sag) because of its surprising ability to stim- Peyer’s patches of suckling pups, followed by retroviral
ulate a large fraction of the murine T cell repertoire (Fran- integration and expression of Sag with MHC class II
kel et al., 1991; Dyson et al., 1991; Choi et al., 1991). products on the B cell surface (Karapetian et al., 1994).
Superantigens are distinguished from conventional anti- Presentation of Sag results in the stimulation of reactive
gens by binding to major histocompatibility complex helper T cells, which induce differentiation and extensive
(MHC) class II products in a region distinct from the clonal expansion of the infected B cells (Chervonsky et
polymorphic peptide binding groove, as well as by being al., 1995; Held et al., 1994, 1993a). In mice lacking Sag-
presented by class II/ cells without extensive proteolytic reactive T cell subsets, MMTV infection is prevented
processing (Mottershead et al., 1995; Dellabona et al., (Held et al., 1993b; Golovkina et al., 1992). Migration of
1990; Yagi et al., 1990). The Sag/class II complex stimu- infected lymphocytes is presumably responsible for the
lates T cells bearing particular T cell receptor (TCR) Vb
eventual infection of the mammary epithelium.
elements (Herman et al., 1991).
MMTV integration into germ cells has resulted in Mtv
Both MMTV infectious viruses and endogenous provi-
proviral integrants that are numerous in all inbred strainsruses produce Sags (Acha-Orbea et al., 1993). All MMTV
and most wild mice (Pullen et al., 1990a; Kozak et al.,Sags share a high degree of sequence homology, except
1987). While most of these integrants have lost the abilityat the carboxy terminus, which is the region that deter-
to make infectious virus, their Sag expression during on-
togeny leads to the deletion of reactive thymocytes (Her-
man et al., 1991). This Vb-specific deletion profoundlyThis work was supported in part by National Institutes of Health
effects the T cell repertoire and immune surveillanceGrant AI-33528. A.M.P. is an Assistant Investigator of the Howard
Hughes Medical Institute and is a Pew Scholar in the Biomedical Sci- (Lukacher et al., 1995; Pullen et al., 1988).
ences. C.W.M. is supported in part by National Institutes of Health Although TCR residues have been identified that con-
Training Grant CA-09537.
tribute to Sag recognition (Pullen et al., 1991, 1990b; Ca-1 To whom correspondence and reprint requests should be ad-
zenave et al., 1990), the biochemistry and cell surfacedressed at Howard Hughes Medical Institute, University of Washington,
Box 357370, Seattle, WA 98195-7370. Fax: (206) 543-0858. presentation of Sag is less well understood. Sags are
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type II glycoproteins, with a short intracellular amino- therefore all constructs were transfected into the B cell
line CH27. We found that any decrease in the numberterminal domain, a membrane-spanning region, and a
large extracellular carboxy-terminal domain (Knight et al., of oligosaccharide additions drastically diminished the
amount of Mtv-1 Sag expressed on the cell surface. A1992; Korman et al., 1992; Choi et al., 1992). On the cell
surface, Sags are found predominantly as a proteolytic construct with all six sites disrupted encoded a Sag that
was no longer presented to most Vb3/ T cell hybrids,cleavage product (Park et al., 1995; Winslow et al., 1992),
perhaps due to processing at one or more subtilisin-like demonstrating that some level of N-linked glycosylation
is required for effective MMTV viral superantigen func-cleavage sites. Such processing may be similar to what
occurs in a variety of cellular and viral surface glycopro- tion. The data obtained suggest that one N-linked oligo-
saccharide addition on Mtv-1 Sag molecules can be suffi-teins, including the insulin proreceptor and all retroviral
envelope glycoproteins (Dickson et al., 1982; Ullrich et cient to stimulate all Vb3/ T cell hybrids tested.
al., 1985). It has been previously shown that Sags are
heavily glycosylated in B cells, and much, if not all, of MATERIALS AND METHODS
the carbohydrate addition is in the form of asparagine-
Mutagenesis and plasmidslinked oligosaccharide (Winslow et al., 1994). Studies em-
ploying PNGase F (N-glycanase) and EndoH digestion The mutagenesis strategy employed is shown in Fig.
of Sags have suggested that the predicted 37-kDa core 1A. The sequences of oligonucleotide primers are shown
protein is initially increased to a molecular mass of 45 in Table 1. To disrupt glycosylation sites at amino acids
kDa by cotranslational N-linked oligosaccharide addition 79, 80, 89, and 93, PCR was first used to generate a gene
in the endoplasmic reticulum (ER) (Brandt-Carlson and fragment between primers 5* sag1 and 3 * 79–93, using
Butel, 1991; Korman et al., 1992). Further variable carbo- the cloned Mtv-1 sag gene (Pullen et al., 1992) as a
hydrate modifications in the Golgi complex, possibly in- template. Primer 3 * 79–93 introduces one NrS and three
cluding O-linked glycosylation, result in a mature glyco- NrQ amino acid changes and a unique XhoI site. An-
protein of variable molecular mass ranging up to approxi- other PCR used primers 5* 79–93, which introduces the
mately 82 kDa (Winslow et al., 1994). Thus, carbohydrate same XhoI site, and 3 * sag1. These PCR fragments were
can comprise up to 55% of the Sag glycoprotein mass. separated in a low-melt agarose gel, and 2-ml quantities
Carbohydrate addition can fulfill several possible func- from each of these bands were then used together as
tional roles for a glycoprotein, including facilitating cor- the templates for sequence overlap extension PCR (Ho
rect intracellular trafficking, solubility, resistance to prote- et al., 1989), using primers 5* sag1 and 3 * sag1. The
olysis, and ligand binding. In addition, for many cell sur- resulting full-length PCR product was digested with
face receptors N-linked glycosylation has been shown EcoRI and BamHI, cloned into pBluescript(SK//0)
to be required for attaining proper conformation during phagemid (Stratagene, La Jolla, CA), and sequenced in
folding in the ER (Hoe and Hunt, 1992; Olson and Lane, its entirety to confirm the desired mutations. Since primer
1987; Slieker et al., 1986). Conversely, glycosylation ap- 5* 79–93 does not encode disruptions in the glycosyla-
pears unnecessary for the trafficking and function of tion sites, clones were also obtained that lacked dis-
many secreted glycoproteins (West, 1986). Our earlier rupted sites, but included the introduced XhoI restriction
studies indicated that preventing TCR glycosylation actu- site. These clones made it possible to subclone regions
ally improved Sag binding (Pullen et al., 1991), and a encoding one or two wild-type glycosylation sites into
similar effect has been reported for IgM binding of a mutant constructs without additional PCR. A similar ap-
cognate ligand (Bazin et al., 1992). proach was used to disrupt glycosylation sites at amino
The Mtv-1 provirus, found in several inbred mouse acids 131 and 146, using the 131–146 primer set. Using
strains, encodes the Vb3-reactive viral superantigen Mtv- the introduced XhoI and XmaIII restriction sites and a
1 Sag (Pullen et al., 1992). The amino acid sequence unique BsmI site found in the Mtv-1 sag nucleotide se-
of Mtv-1 Sag includes six potential sites for N-linked quence, a panel of constructs was generated that en-
glycosylation (the amino acid motif N-X-S/T), all of which codes mutant Sags with some or all of the glycosylation
lie in the extracellular domain. Five of these sites (N79, sites disrupted, as represented in Fig. 1B. These con-
N89, N93, N131, and N146) are conserved among infec- structs were subsequently subcloned into the pHbAPr-
tious MMTVs and proviral integrants (Brandt-Carlson et 1 expression vector, which employs the b-actin promoter
al., 1993). To address the functional significance of Mtv- and confers G418 resistance (Gunning et al., 1987).
1 Sag carbohydrate addition, we performed site-directed
mutagenesis on the six motifs. A panel of mutants con- Cell lines and transfection
taining disruptions in combinations of these motifs was
generated, followed by characterization of their biochem- Transfectants of the B cell lymphoma CH27 (H-2a)
(Haughton et al., 1986) expressing wild-type and mutantical and functional properties. B lymphocytes are the cen-
tral Sag-presenting cells in vivo (Held et al., 1993a,b); Mtv-1 Sags were generated by linearizing the expression
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constructs described above with ScaI, followed by elec- ity at the University of Washington. This peptide corre-
sponds to amino acids 294–308 of Mtv-1 Sag, with thetroporation with a Promega X-Cell 450 electroporator
(375 V, 1400 mF, 50 msec) (Madison, WI). Transfected addition of a cysteine residue to facilitate covalent cou-
pling to KLH using an Imject conjugation kit (Piercecells were cloned at limiting dilution and selected with
1.3 mg/ml G418. 10–40 clones from each transfection Chemical Co., Rockford, IL). New Zealand White rabbits
were injected sc with 400 mg of P2/KLH conjugate emul-were screened in stimulation assays using Vb3/ T cell
hybrids K25-59.6, K25-49.16 (Pullen et al., 1988), and 5KC- sified with CFA. Four subsequent injections were made
using IFA. Antisera were tested by ELISA for P2 reactivity73.8.11 (White et al., 1993). The Vb7/ hybrid KOX7-6.6
(Choi et al., 1991) served as a negative control. (data not shown) and by flow cytometric analysis for bind-
ing to CH27 cells transfected with Mtv-1 Sag.
Affinity purification and Western blotting
Flow cytometric analysisAffinity purification and Western blot analysis of Mtv-
1 Sag was carried out, with minor modifications, as pre-
To block antibody binding to Fc receptors, cells were
viously described for Mtv-7 Sag (Winslow et al., 1994).
preincubated for 15 min at 377 in an anti-FcgRII/III hybrid-
Briefly, VS1, a mAb recognizing the amino terminus of all
oma supernatant (2.4G2) (Unkeless, 1979) containing
MMTV-encoded superantigens, was conjugated to cy-
0.1% NaN3 . Rabbit anti-Mtv-1 Sag serum or prebleed se-anogen bromide-activated Sepharose. CH27 cells ex-
rum was then added at a final dilution of 1:300, and
pressing mutant Mtv-1 Sags were lysed at 108/ml in PBS
incubation was continued for 1 hr. Where indicated, com-
containing 1% NP-40, 20 mg/ml aprotinin, 2 mg/ml leupep-
petitor P2 peptide was added at 25 mM. Secondary and
tin, 2 mM pepstatin, 30 mM iodoacetamide, 0.1% NaN3 , tertiary antibodies were mouse anti-rabbit Ig (Pierce)
5 mM EDTA, 100 mM TLCK, and 0.5 mM PMSF (all from
coupled to digoxigenin as above and sheep anti-digoxi-
Sigma Chemical Co., St. Louis, MO). After rocking for 1
genin-FITC Fab (Boehringer Mannheim), respectively. In-
hr at 47, lysates were clarified by centrifugation for 1 hr at
cubations were for 30 min on ice.
64,000 g. Clarified lysates were run over the VS1 affinity
For intracellular staining, cells were preincubated 10
column at 47, and the column was washed with PBS/
min in 50% normal mouse serum and 50% 2.4G2 superna-
0.5% NP-40/ 0.1% SDS, followed by 2 mM NH4HCO3 . tant containing 0.03% saponin (Sigma). Biotinylated VS1
Bound material was eluted with 50 mM diethylamine and
mAb was added at 3 mg/ml (30 min, 257) with or without
was lyophilized. After resuspension in a small volume of
25 mM competitor peptide, followed by tricolor-coupled
0.5% SDS/ 1% 2ME, samples were treated with either 5
streptavidin (Caltag Laboratories, So. San Francisco, CA).
or 1.5 ml PNGase F (New England Biolabs, Beverly, MA)
The reproducibility of permeabilization and intracellular
overnight.
staining was assessed with In1, a mAb recognizing in-
For Western analysis, VS1-column eluate correspond-
variant chain (Koch et al., 1982). Incubation with In1 su-
ing to 2 1 108 cell equivalents (per lane) was electropho-
pernatant was followed with FITC-mouse anti-rat F(ab*)2resed in 10% SDS polyacrylamide gel and transferred
(Accurate Chemical and Scientific, Westbury, NY).
to nitrocellulose membrane. Blots were blocked in PBS
Washes and incubations were in PBS containing 1% BSA,
containing 5% nonfat dry milk and 0.1% Tween 20. Sag
0.1% NaN3 and 0.03% saponin. All samples were ana-protein was probed with VS1 (10 mg/ml), with or without
lyzed using a FACScan (Becton–Dickinson & Co., Sun-
12 mM competing peptide (Winslow et al., 1994). A
nyvale, CA) and ReproMan software (TrueFacts Software
mouse anti-Armenian hamster IgH monoclonal antibody,
Inc., Seattle, WA).
HIG632.13 (Winslow et al., 1992), was coupled to acti-
vated digoxigenin ester (Boehringer Mannheim, India-
T cell stimulation assaynapolis, IN) at 100 mg DIG/mg mAb and was used at
0.2 mg/ml, followed by anti-DIG-peroxidase Fab (1:8000,
Stimulation assays were carried out as previously de-
Boehringer Mannheim). All washes and antibody incuba-
scribed (Morishima et al., 1994). Briefly, 105 CH27 cells
tions were carried out at room temperature in PBS with
or Mtv-1 Sag transfectants were cocultured with 105 T
3% milk and 0.1% Tween 20. The ECL chemilumines-
cell hybrids for 24 hr at 377. The supernatants of these
cence system (Amersham Life Science Inc., Arlington
cultures were assayed for lymphokine production with
Heights, IL) was used for visualization. The VS1-2.8 cell
the IL-2-dependent cell line, HT-2 (Kappler et al., 1981).
line was a generous gift of Dr. Gary Winslow (Wadsworth
Survival of HT-2 cells was measured using alamarBlue
Center for Laboratories and Research, Albany, NY).
(Alamar Biosciences Inc., Sacramento, CA). Values pre-
sented in Table 2 are averages of triplicate wells. EachAntisera production
transfectant was assayed in at least three independent
experiments. The data from one representative experi-Peptide P2 (NH2-CYNSREEAKRHIIEHI) was synthe-
sized and purified by the Molecular Pharmacology Facil- ment are shown.
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TABLE 1











Quantitation of Mtv-1 Sag-specific mRNA under the control of the human b-actin promoter and
were transfected into the B cell line CH27. StableRNA was isolated from stable transfectants using
transfectants with high levels of Mtv-1 Sag-specificRNAzol B (Tel-Test, Inc., Friendswood, TX), and cDNA
mRNA were selected for further analysis. Semiquantita-was synthesized using oligo(dT)12 – 18 primer and Super-
tive RT–PCR confirmed that the wild-type and all mutantscript II reverse transcriptase (GibcoBRL, Gaithersburg,
MD). Primers specific for Mtv-1 sag (5* sag1 and 3 * sag1/
6, Table 1) were used for PCR amplification. Threefold
serial dilutions of cDNA served as PCR templates, and
the most dilute sample yielding a detectable PCR product
was considered the Mtv-1 Sag mRNA titer. These titers
were then normalized to HPRT-specific PCR reactions
carried out upon cDNA from each mutant, using the same
titrations and conditions, to control for overall cDNA lev-
els among samples (Reiner et al., 1993). All dilutions and
PCRs were repeated at least once. Transfectants with
similar Mtv-1 Sag mRNA levels were chosen for further
study.
RESULTS
Disruption of potential N-linked glycosylation sites
We employed site-directed mutagenesis to determine
the role of N-linked glycosylation in the generation of
functional MMTV-encoded superantigens. Sequence
overlap extension PCR was used to introduce mutations
in various combinations of the six potential sites for N-
linked oligosaccharide addition on Mtv-1 Sag (Fig. 1A).
At five of the six positions, Asn residues of the N-X-S/T
motif were replaced with Gln. This conservative AsnrGln
substitution should have minimal effect on protein tertiary
structure while preventing oligosaccharide transfer. At
position 80, an AsnrSer change was made because this
substitution mimics the serine residue found at the same
position in Mtv-7 Sag (Beutner et al., 1992). Mutants with
various disrupted glycosylation motifs are represented
FIG. 1. Mtv-1 Sag mutants lacking sites for N-linked glycosylation.in Fig. 1B.
(A) Primers used to introduce mutations via sequence overlap exten-
mRNA and Western blot analysis of Mtv-1 sion PCR. Introduced restriction sites are labeled on the primers, and
nucleotide changes that result in disruption of glycosylation sites areSag mutants
denoted with open circles. (B) Panel of mutant Mtv-1 Sag proteins.
Wild-type Mtv-1 Sag and the mutant constructs de- Remaining sites for potential N-linked addition are represented as trian-
gles.scribed above were cloned into an expression vector
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Without PNGase F treatment, wild-type Mtv-1 Sag gly-
coprotein migrates predominantly as a band of molecular
mass of 45 kDa (gp45), as previously reported for other
Sags (Korman et al., 1992; Brandt-Carlson and Butel,
1991; Krummenacher and Diggelmann, 1993). EndoH
treatment has identified gp45 as the ER-associated form
of the glycoprotein that is cotranslationally modified with
core oligosaccharides (Winslow et al., 1994). Each of the
high-mannose moieties adds approximately 2 kDa to the
molecular mass of an immature glycoprotein; therefore,
the decreased mobility of deglycosylated Mtv-1 Sag (8
kDa) suggests that the wild-type glycoprotein is modified
with four N-linked oligosaccharide additions. Mutant
D79,80 also migrates at a molecular mass of 45 kDa,
suggesting that N-linked glycosylation is occurring at allFIG. 2. Mtv-1 Sag mRNA levels of transfectants. RNA was isolated
four remaining sites in this mutant.from clones of stable transfectants and was reverse transcribed. Three-
fold serial dilutions of these cDNAs served as templates for PCRs using Mutant D79,80,89,93 yields a prominent band of 41
Mtv-1 sag-specific primers. The last template dilution to yield a PCR kDa (gp41), corresponding to a deficit of two high-man-
product was considered the cDNA titer. To control for variation between nose oligosaccharides with respect to wild type and a
cDNA preparations, these Sag mRNA titers were normalized using
more faint band at 39 kDa. This result suggests that bothHPRT-specific PCRs of the same cDNA serial dilutions. Sag mRNA
amino acids N131 and N146 are generally glycosylated,levels of the mutant transfectants are shown relative to the wild-type
Mtv-1 Sag transfectant. but that perhaps some of the glycoprotein is glycosylated
at only one of these sites. Mutant D131,146 also yields
a prominent gp41 moiety, indicating that only two of theMtv-1 Sag transfectants used in subsequent experiments
remaining four motifs (N79, N80, N89, N93) are glycosyl-expressed similar levels of Mtv-1 Sag mRNA (Fig. 2).
ated in this mutant. The increased mobility observed withCell lysates were run over a VS1 affinity column that
these mutants is not the result of proteolytic degradation,binds the Sag N-terminus. Material eluted from this col-
because treatment of these glycoproteins with PNGaseumn was in some cases treated with PNGase F (N-glyca-
F yields predominantly p37 in all cases.nase), followed by SDS– PAGE, transfer to nitrocellulose,
Sag protein cannot be detected by Western analysisand immunoblotting with the same mAb. The enrichment
in the remaining mutants (D79,80,89,93,131, D89,93,step preceding Western analysis has been shown to be
131,146, D79,80,131,146, and D79,80,89,93,131,146), andnecessary; despite the fact that the constructs are ex-
therefore the glycosylation status of these mutants can-pressed by a strong promoter, approximately 2 1 108
cell equivalents are needed to detect Sag protein by
immunoblotting (Winslow et al., 1992, and our unpub-
lished data). Although VS1 also recognizes endogenous
Sags expressed in the CH27 cell line, these Sags are
expressed at almost undetectable levels, allowing analy-
sis of transfected mutants (Fig. 3). Moreover, these en-
dogenous Sags are not Vb3-reactive and therefore did
not interfere with stimulation assays using Vb3/ T hy-
brids.
Following treatment with PNGase F, wild-type Mtv-1
Sag and all mutants with detectable levels of protein
migrated as a doublet of 37 and 39 kDa (Fig. 3). p37
FIG. 3. Western blot analysis of mutants. Mtv-1 Sag was purifiedcorresponds to the predicted core molecular mass of
from clarified cell lysates over a VS1 affinity column, run on SDS–Mtv-1 Sag (36.5 kDa); although VS1 cross-reacts with a
PAGE, transferred to nitrocellulose membrane, and blotted with VS1.
faint 37-kDa species in all lanes, Mtv-1 Sag is conspicu- PNGase F/ indicates sample was treated with 5 or 1.5 ml N-glycanase
ous in its intensity. The 39-kDa band most likely repre- prior to electrophoresis. Note that in samples where 5 ml PNGase F
was used, the protein is detected on the blot. This is the only bandsents incomplete digestion by PNGase F, because this
seen on membranes blotted with VS1 in the presence of 12 mM compet-band, and bands of greater molecular mass, increased
itor peptide. The maturing, post-ER glycoproteins, which migrate asin intensity with less exhaustive digestion (data not
faint species of heterogeneous molecular mass (50–82 kDa), and the
shown). The 32-kDa protein is PNGase F, which was 24-kDa putative proteolytic cleavage products ((Winslow et al., 1994),
detected by the secondary antibody in cases when more data not shown) that were detected inconsistently, are not included in
the figure.enzyme was used to maximize oligosaccharide removal.
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not be determined directly. This result is most likely due 89,93,131, which can only be glycosylated on amino acid
146, has significant stimulatory ability, demonstratingto the low levels of protein present in these cells, as
suggested by intracellular staining (Fig. 4) and as dis- that in this instance one N-linked addition is adequate
for presentation to all of the Vb3/ T cell hybrids tested.cussed in more detail below. In summary, the mutants
with detectable shifts in molecular mass suggest that Not all mutant Sag proteins that can be glycosylated at
one or more sites exhibit this level of activity, however.wild-type Mtv-1 Sag is generally glycosylated at amino
acids N131 and N146 and at two of the four remaining Two mutants that are potentially glycosylated at two sites
(D89,93,131,146 and D79,80,131,146) elicit little or nomotifs, resulting in a total of four N-linked oligosaccha-
ride additions. IL-2 production by the Mtv-1 Sag-reactive hybrids. One
extremely sensitive T cell hybrid, 5KC-73.8.11, secretes
Cell surface and intracellular expression of Mtv-1 Sag low levels of IL-2 in response to mutants that cannot
mutants stimulate any of the other Vb3/ hybrids. This is probably
a reflection of these mutants yielding a trace amount of
Rabbits were injected with peptide/ KLH conjugates
functional Mtv-1 Sag protein on the cell surface.
to generate antisera specific for the extracellular carboxy
It should be noted that mutants D79,80,89,93 and
terminus of Mtv-1 Sag. One of the antisera obtained
D131,146 both stimulate IL-2 production by Vb3/ hy-
readily allowed detection of wild-type Mtv-1 Sag on the
brids. Since these two mutants encompass the disruption
surface of transfected CH27 cells by flow cytometry (Fig.
of all possible glycosylation motifs, this suggests that
4). However, surface expression of all glycosylation mu-
there is no particular site for carbohydrate addition that
tants was undetectable, with the exception of trace stain-
is critical for Mtv-1 Sag function. In addition, these results
ing reproducibly seen on mutant D79,80. To rule out the
imply that none of the amino acid changes grossly per-
possibility that reduced N-linked glycosylation of mutants
turb Mtv-1 Sag conformation, since both of these mutants
might affect epitopes recognized by the anti-Mtv-1 Sag
are effectively presented to T cells. Therefore, we infer
antiserum, the antiserum was shown to effectively block
that the defect of the nonstimulatory mutants is due to
in vitro stimulation of Vb3/ T cell hybrids by CH27 cells
their glycosylation status.
expressing stimulatory mutant constructs (data not
shown). Therefore, we conclude that even a modest re-
DISCUSSIONduction in glycosylation results in a marked decrease in
Mtv-1 Sag surface expression.
The functional role of MMTV-encoded superantigens
In contrast, Sag protein was detectable by intracellular
in promoting proviral amplification during infection and
VS1 staining of saponin-permeabilized cells expressing
the requirement for Vb-specific stimulation for viral trans-
mutant Sags, with the exception of the mutant lacking
mission to the next generation is well established (Acha-
all potential N-linked glycosylation sites (Fig. 4). In most
Orbea and MacDonald, 1995). However, several aspects
mutants, the intracellular levels of Sag were greatly re-
of Sag trafficking, processing, and cell surface presenta-
duced compared to wild type. This reduction was not
tion remain poorly understood. In this report, we address
due to a decrease in Mtv-1 Sag-specific mRNA, since
the importance of the extensive and variable N-linked
mRNA levels between the mutants and wild-type do not
oligosaccharide modification of Sags. We show that pre-
differ significantly (Fig. 2). One mutant, D131,146, had
venting glycosylation at increasing numbers of potential
almost wild-type levels of intracellular Sag and yet lacked
N-linked sites results in increasingly poor intracellular
detectable cell surface expression.
Mtv-1 Sag stability, surface expression, and stimulation
of reactive T cell hybrids. In the most extreme case, Mtv-Functional effects of abrogating N-linked
1 Sag lacking any N-linked glycosylation cannot be de-glycosylation
tected within the cell or on the cell surface by staining
or biochemical means, and the extremely low levels ofCH27 cells transfected with mutant constructs were
assayed for the ability to stimulate a panel of T cell hy- this mutant protein can only be detected by one particu-
larly sensitive Vb3/ T cell hybrid.brids. As seen in Table 2, Vb3/ T cell hybrids secrete
high levels of IL-2 when incubated with CH27 cells ex- There are several possible explanations for why Sags
require N-linked glycosylation to be presented correctlypressing wild type Mtv-1 Sag. However, cells expressing
the Mtv-1 Sag mutant lacking all N-linked glycosylation to T cells. Carbohydrate may directly contribute to the
Sag interaction with MHC class II or the TCR. However,motifs (D79,80,89,93,131,146) did not stimulate most
Vb3/ T cell hybrids (Table 2 and data not shown). Several since prevention of any individual N-linked oligosaccha-
ride addition does not eliminate T cell recognition, ourother mutants with intermediate numbers of ablated N-
linked glycosylation sites stimulate all Vb3/ T cell hy- data indicate that such carbohydrates are unlikely to play
an essential role in Sag binding to these molecules. Alter-brids tested, indicating that full glycosylation of Mtv-1
Sag is not necessary for function. Most notably, D78,80, natively, perhaps glycosylation protects the glycoprotein
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FIG. 4. Cell surface and intracellular expression of Mtv-1 Sag mutants. To measure Mtv-1 Sag surface expression, transfectants were stained
with anti-Mtv-1 Sag antiserum, in the presence (plain lines) or the absence (bold lines) of competitor peptide P2 or with prebleed serum (dashed
lines). For intracellular staining, transfectants were permeabilized with saponin and stained with biotinylated VS1 mAb, in the presence (plain lines)
or the absence (bold lines) of competitor peptide or with no primary Ab (dashed lines). To detect intracellular invariant chain, permeabilized
transfectants were stained with In1 mAb (bold lines) or secondary antibody only (dashed lines). Fluorescence intensity is represented on a logarithmic
scale on the x-axis.
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TABLE 2
Stimulation of T Cell Hybridomas by Mtv-1 Sag Glycosylation Site Mutants
IL-2 production by T cell hybrids (U/ml)
K25-59.6 5KC-73.8.11 K25-49.16 K0X7-6.6
(Vb3/) (Vb3/) (Vb3/) (Vb7/)
CH27 — a — — —
Mtv-1 Sag (wt) 1600 796 768 —
D79, 80 341 599 473 —
D79, 80, 89, 93 129 296 217 —
D131, 146 355 849 491 —
D79, 80, 89, 93, 131 68 231 83 —
D89, 93, 131, 146 5 39 9 —
D79, 80, 131, 146 — 7 — —
D79, 80, 89, 93, 131, 146 — 15 — —
a — Indicates £ 5U IL-2/ml.
from proteolytic degradation during trafficking and pre- of protein instability, but may instead be a reflection of
improper targeting and transport from the ER.sentation. This possibility seems especially plausible if
Sag traffics together with MHC class II via protease-rich It is interesting that any decrease in glycosylation re-
sults in cell surface Mtv-1 Sag levels that are undetect-endocytic compartments. We feel, however, that in most
cases the most straightforward explanation for the atten- able by staining, and yet many of these mutants are able
to effectively stimulate T cells. This apparent discrepancyuated Sag presentation is that the glycosylation mutants
are improperly folded in the ER and are degraded more may be reconciled by the observation that T cell hybrids
secrete IL-2 in response to extremely low levels of pre-rapidly than wild-type Mtv-1 Sag protein.
N-linked glycosylation has been shown to be important sented antigen (Harding and Unanue, 1990). We have
also observed that T cell stimulation is more sensitivefor the proper folding and trafficking of many cell surface
glycoproteins, including the GLYT1 glycine transporter than surface staining as a method for detecting Sags
expressed by LPS-stimulated B cell blasts (data notand the transferrin receptor (Williams and Enns, 1993;
Olivares et al., 1995). High-mannose oligosaccharides shown). In addition, after extended periods in culture,
variants of CH27 transfectants expressing wild-type Mtv-appear to play a role in early glycoprotein association
with molecular chaperones such as calnexin and BiP, 1 Sag can be isolated; these variants also stimulate Vb3/
hybrids to produce IL-2 in the same range as the glyco-which guide stable folding in the ER (Ware et al., 1995).
Improperly folded proteins are retained in the ER, and sylation site mutants, despite having undetectable Mtv-
1 Sag surface expression by flow cytometry (data notare quickly destroyed. Moreover, MMTV Sags are rich
with Pro, Glu, Ser, and Thr residues (‘‘PEST’’ sequences) shown). These results have important implications for
MMTV infection, as they demonstrate that Vb-specific Tthat earmark proteins for rapid degradation (Rechsteiner,
1990; Stellwagen, 1992; Rogers et al., 1986), and cell activation is exquisitely sensitive to low level Sag
expression.MMTV(GR) Sag has been demonstrated to have a short
half-life of less than 2 hr in vitro (Krummenacher and Several observations suggest that use of individual
glycosylation sites on Mtv-1 Sag mutants may differ de-Diggelmann, 1993). It therefore seems likely that improp-
erly folded glycosylation mutants would be extremely pending upon which combination of sites are available.
For instance, although mutant D79,80 and wild-type Mtv-short-lived and would only be present at low levels.
It is noteworthy that the majority of Sag glycoprotein 1 Sag have the same apparent molecular mass, they
differ in Mtv-1 Sag surface expression (Fig. 4) and theirdetected by immunoblotting is EndoH-sensitive and is
inferred to reside in the ER (Winslow et al., 1994). There- ability to stimulate reactive T cell hybrids (Table 2). One
possible interpretation is that mutant D79,80 and wild-fore, the decreased levels of intracellular Sag mutants
observed with flow cytometry suggest that the mutant type Mtv-1 Sag are glycosylated at different sites, despite
having the same number of carbohydrate additions. Alter-glycoproteins are subject to degradation before leaving
the ER. An intriguing exception to this trend is found in natively, it is formally possible that in wild-type Mtv-1 Sag
residues N79 and N80 are not glycosylated, but maymutant D131,146, which exhibits near wild-type levels of
intracellular Sag, yet Mtv-1 Sag cannot be detected on contribute to folding, interaction with MHC class II, or
intracellular trafficking.the cell surface. In this case the lack of mutant Mtv-1
Sag surface expression may not be a direct consequence The functional data also have implications for the mu-
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in the open reading frame of the 3* long terminal repeat of mousetants that are not detected by immunoblotting (Fig. 3).
mammary tumour virus. Nature 350, 203–207.For example, we infer that mutant D79,80,89,93,131 is
Choi, Y., Marrack, P., and Kappler, J. (1992). Structural analysis of a
most likely glycosylated at amino acid N146, since this mouse mammary tumor virus superantigen. J. Exp. Med. 175, 847–
mutant is able to effectively stimulate all the Vb3/ hy- 852.
Dellabona, P., Peccoud, J., Kappler, J., Marrack, P., Benoist, C., andbrids, while the mutant lacking all N-linked glycosylation
Mathis, D. (1990). Superantigens interact with MHC class II mole-sites, D79,80,89,93,131,146, stimulates only poorly the
cules outside of the antigen groove. Cell 62, 1115–1121.most sensitive hybrid.
Dickson, C., Eisenmann, R., Fan, H., Hunter, E., Teich, N., and Varmus,
We have studied the impact of N-linked glycosylation H. (1982). Protein biosynthesis and assembly. In ‘‘RNA Tumor Virus’’
on Sag presentation to understand better how MMTV (R. Weiss, N. Teich, and H. Varmus, Eds.), pp. 513–648. Cold Spring
Harbor Laboratory, Press, Cold Spring Harbor, NY.utilizes viral superantigens to exploit the murine immune
Dyson, P. J., Knight, A. M., Fairchild, S., Simpson, E., and Tomonari,system. We show that extensive glycosylation is neces-
K. (1991). Genes encoding ligands for detection of Vb11 T cellssary for high levels of Mtv-1 Sag surface expression on
cosegregate with mammary tumour virus genomes. Nature 349, 531–
antigen-presenting cells. However, several mutants with 532.
intermediate levels of glycosylation express levels of Frankel, W. N., Rudy, C., Coffin, J. M., and Huber, B. T. (1991). Linkage
of Mls genes to endogenous mouse mammary tumour viruses ofMtv-1 Sag on the B cell surface sufficient to stimulate
inbred mice. Nature 349, 526–528.reactive T cell hybrids. While addition of a single N-linked
Golovkina, T., Chervonsky, A., Dudley, J., and Ross, J. (1992). Transgeniccarbohydrate can confer significant activity, ablation of
mouse mammary tumor virus superantigen expression prevents viral
all glycosylation sites results in a poorly functional Sag infection. Cell 69, 637–645.
that is unable to stimulate most members of a panel of Gunning, P., Leavitt, J., Muscat, G., Ng, S., and Kedes, L. (1987). A human
b-actin expression vector system directs high-level accumulation ofreactive T cell hybrids. Taken together, the data pre-
antisense transcripts. Proc. Natl. Acad. Sci. USA 84, 4831–4835.sented indicate that effective presentation of MMTV su-
Harding, C. V., and Unanue, E. (1990). Quantitation of antigen-present-perantigens requires N-linked carbohydrate addition.
ing cell MHC class II/peptide complexes necessary for T-cell stimula-
tion. Nature 346, 574–576.
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